Skip to main content
Log in

Clinical significance of serum iron and ferritin in patients with colorectal cancer

  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

To clarify the significance of serum iron and ferritin as indicators of iron loss caused by continuous bleeding, and, thus, to determine their value as markers of colorectal cancer, values for the two were compared in male patients with early and advanced colorectal cancer and age-matched male controls. The mean value of serum iron levels in patients with advanced colorectal cancer was significantly decreased compared with values in patients with early colorectal cancer and controls, 50.5 ± 38.6μg/dl vs 93.0 ± 32.1 μg/dl and 107.1 ± 32.9μg/dl, respectively (p < 0.001). The mean value of serum ferritin levels in patients with early and advanced colorectal cancer was also significantly decreased compared with controls, 80.5 ± 35.0ng/ml (p < 0.01) and 48.8 ± 72.8 ng/ml (p < 0.001), respectively, vs 117.1 ± 46.8 ng/ml. However, there was no significant difference between mean serum iron levels in patients with early colorectal cancer and controls. Eighteen (78.3%) of the 23 patients with advanced colorectal cancer and 3 (16.7%) of the 18 patients with early colorectal cancer had serum iron levels below 85μg/dl and serum ferritin levels below 60ng/ml. Levels of both serum iron and ferritin, without clinically evident anemia, are useful indicators of advanced colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Niitsu Y, Kohgo Y, Yokota M, et al. Radioimmunoassay of serum ferritin in patients with malignancy. Ann N Y Acad Sci 1975;259:450–452.

    PubMed  Google Scholar 

  2. Tsujino D, Yomoda Y, Sekita N, et al. Clinical study of plasma ferritin levels in patients with cancer (in Japanese). Jpn J Cancer Clin 1982;28:1633–1637.

    Google Scholar 

  3. Sato M, Shimizu H, Kiyasu Y et al. Clinical significance of serum ferritin determination of cancer patients in gastroenterological surgery (in Japanese). Jpn J Gastroenterol Surg 1986; 15:1379–1386.

    Google Scholar 

  4. Hamazoe R, Osaki Y, Maeta M, et al. Clinical significance of serum ferritin level in carcinoma of the stomach and colon (in Japanese). J Jpn Soc Cancer Ther 1985;20:2222–2228.

    Google Scholar 

  5. Zavagno G, Nitti D, Marchet A, et al. Significance of serum ferritin in patients with gastric and colorectal cancer. Eur J Cancer Clin Oncol 1987;23:1077–1078.

    PubMed  Google Scholar 

  6. Harju E, Lindberg H. Lack of iron stores in patients with diseases of the gastrointestinal tract. Surg Gynecol Obstet 1985; 161:362–366.

    PubMed  Google Scholar 

  7. Addison GM, Beamish MR, Hales CN, et al. An immunoradiometric assay for ferritin in serum of normal subjects and patients with iron deficiency and iron overload. J Clin Pathol 1972;25:326–329.

    PubMed  Google Scholar 

  8. Lipschitz DA, Cook JD, Finch CA, et al. A clinical evaluation of serum ferritin as an index of iron stores. New Engl J Med 1974;290:1213–1216.

    PubMed  Google Scholar 

  9. Prieto J, Barry M, Sherlock S. Serum ferritin in patients with iron overload and with acute and chronic liver disease. Gastroenterology 1975;68:525–533.

    PubMed  Google Scholar 

  10. Niitsu Y, Kohgo Y, Ohtsuka S, et al. Radioimmunoassay of serum ferritin in various liver diseases and its clinical significance (in Japanese). Acta Hepatol Jpn 1975;16:631.

    Google Scholar 

  11. Nakano S, Kumada T, Kitamura K, et al. Clinical evaluation of serum ferritin in the diagnosis of liver disease (in Japanese). Jpn J Gastroenterol 1979;76:1306–1313.

    Google Scholar 

  12. Marcus DM, Zinberg N. Measurement of serum ferritin by radioimmunoassay: Results in normal individual and patients with breast cancer. J Natl Cancer Inst 1975;55:791–795.

    PubMed  Google Scholar 

  13. Group C, Havemann K, Lehmann FG. Carcinoembryonic antigen and ferritin in patients with lung cancer before and during therapy. Cancer 1978;42:2802–2808.

    PubMed  Google Scholar 

  14. Jones PA, Miller FM, Worwood M, et al. Ferritinaemia in leukaemia and Hodgkin's disease. Br J Cancer 1973;27:212–217.

    PubMed  Google Scholar 

  15. Mori W, Asakawa H, Taguchi T. Antiserum against leukemia cell ferritin as a diagnostic tool for malignant neoplasma. J Natl Cancer Inst 1975;55:513–518.

    PubMed  Google Scholar 

  16. Hazard JT, Drysdale JW. Ferritinaemia in cancer. Nature 1977; 265:755–756.

    PubMed  Google Scholar 

  17. Watanabe N, Niitsu YU, Koseki J, et al. A mechanism for elevation of serum ferritin in malignancy: A study of nude mice with innoculated human tumors (in Japanese). J Clin Exp Med (Igaku no Ayumi) 1979;110:686–688.

    Google Scholar 

  18. Campo E, Palacin A, Benasco C, et al. Ferritin immunohistochemical localization in normal and neoplastic colon mucosa. Int J Biol Markers 1987;2:177–183.

    PubMed  Google Scholar 

  19. Niitsu Y. Serum ferritin and malignancy (in Japanese). Jpn J Clin Hematol 1980;21:1135–1143.

    Google Scholar 

  20. Yoshii M, Kohsaka T, Nakajima K, et al. Clinical evaluation of serum ferritin-iron ratio in the diagnosis of malignant diseases (in Japanese). Jpn J Nucl Med 1980;17:317–323.

    Google Scholar 

  21. Niitsu Y, Koseki J, Watanabe N, et al. Diagnosis of latent iron deficiency by serum ferritin concentration (in Japanese). Jpn J Clin Hematol 1979;20:l-7.

    Google Scholar 

  22. Doi K, Takeuchi Y, Maekawa M, et al. Basic study of the method for measurement of serum ferritin and its clinical application (in Japanese). Igaku to Yakugaku 1982;8:2130–2136.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kishida, T., Sato, J., Fujimori, S. et al. Clinical significance of serum iron and ferritin in patients with colorectal cancer. J Gastroenterol 29, 19–23 (1994). https://doi.org/10.1007/BF01229068

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01229068

Key words

Navigation